Stocks Rated
SHOWING 40 OF 152
ABUS Arbutus Biopharma Corp Buy = MAINTAIN Nov 14, 2025
ACFN Acorn Energy, Inc. Hold ▼ DOWNGRADE May 13, 2014
ADMA ADMA Biologics, Inc. Buy = MAINTAIN Jul 30, 2018
AKTX Akari Therapeutics, Plc Neutral ▲ UPGRADE May 31, 2017
ALDX Aldeyra The Buy = MAINTAIN Mar 25, 2015
ALLT Allot Ltd. Buy ▲ UPGRADE Dec 17, 2012
ALMS Alumis Inc. Buy = MAINTAIN May 19, 2026
ALNY Alnylam Pharmaceuticals, Inc. Buy = MAINTAIN Jul 31, 2026
ALUR ALUR Buy ▲ UPGRADE Feb 24, 2026
AMBA Ambarella, Inc. Neutral = MAINTAIN Mar 7, 2016
ANIX Anixa Biosciences, Inc. Buy = MAINTAIN Mar 22, 2023
ANNX Annexon, Inc. Buy = MAINTAIN Mar 20, 2026
ANRO Alto Neuroscience, Inc. Buy = MAINTAIN Apr 22, 2026
ARWR Arrowhead Pharmaceuticals, Inc. Buy = MAINTAIN Jul 22, 2026
ASMB Assembly Biosciences, Inc. Neutral ▼ DOWNGRADE Apr 12, 2018
ASTC Astrotech Corporation Buy = MAINTAIN Oct 28, 2016
BOLD Boundless Bio, Inc. Neutral ▼ DOWNGRADE Dec 3, 2019
BOOM DMC Global Inc. Buy = MAINTAIN Apr 10, 2019
CABA Cabaletta Bio, Inc. Buy = MAINTAIN Mar 22, 2023
CAMP CAMP4 Therapeutics Corporation Buy = MAINTAIN Dec 7, 2015
CAMT Camtek Ltd. Buy ▲ UPGRADE Jun 25, 2013
CEVA CEVA, Inc. Buy ▲ UPGRADE May 5, 2015
CGTX Cognition Therapeutics, Inc. Buy = MAINTAIN Mar 27, 2026
CIFR Cipher Mining Inc. Buy = MAINTAIN Aug 4, 2026
CLSK CleanSpark, Inc. Buy = MAINTAIN Aug 10, 2026
CNTA CNTA Buy = MAINTAIN Jan 2, 2026
CORZ Core Scientific, Inc. Neutral ▼ DOWNGRADE Oct 27, 2022
COYA Coya Therapeutics, Inc. Buy = MAINTAIN Aug 12, 2026
CRGO Freightos Limited Ordinary shares Buy = MAINTAIN May 23, 2024
CRIS Curis, Inc. Buy = MAINTAIN Sep 30, 2013
CRSP CRISPR Therapeutics AG Buy = MAINTAIN Feb 17, 2026
CRVO CervoMed Inc. Buy = MAINTAIN Mar 18, 2026
CSTE Caesarstone Ltd. Buy ▲ UPGRADE Jan 8, 2018
DFLI Dragonfly Energy Holdings Corp. Buy = MAINTAIN Apr 16, 2024
DRIO DarioHealth Corp. Buy = MAINTAIN Apr 9, 2018
DRUG Bright Minds Biosciences Inc. Buy = MAINTAIN Jan 2, 2026
DYN Dyne Therapeutics, Inc. Buy = MAINTAIN Mar 9, 2026
EBS Emergent BioSolutions Inc. Buy = MAINTAIN Nov 9, 2022
EDIT Editas Medicine, Inc. Buy = MAINTAIN May 5, 2026
ESPR ESPR Neutral = MAINTAIN Mar 27, 2018